Sentence examples for demonstrating a delay from inspiring English sources
In an open-label study design, the neurological deficits in 11 patients with the cerebellar type of MSA (MSA-C), who received consecutively intra-arterial and three repeated intravenous injections for three months, were compared with non-treated MSA patients, demonstrating a delay in progression of neurological deficits after MSC therapy [22].
The safety and efficacy of denosumab versus zoledronic acid was established in a randomized trial, demonstrating a delay in skeletal-related events in metastatic castration-resistant prostate cancer patients.
This probably reflects the poor overall chemosensitivity of melanoma, although fotemustine [ 12] did fare somewhat better than dacarbazine in demonstrating a delay in the onset of brain metastases; the median time to brain metastases was 22.7 months (95% confidence interval (CI), 9.62 23.33) in the fotemustine arm versus 7.2 months (95% CI, 6.28 11.70) in the DTIC arm (P = .059).059
Additionally, active immunization of rhesus monkeys with P. knowlesi AMA-1 adjuvanted in saponin resulted in some animals demonstrating a delayed prepatent period when challenged with P. knowlesi schizonts [13].
Arguing that the exocytosis process and the endosome recycling pathway shares common protein components and are functionally related, our data demonstrating a delayed kinetics of transferrin recycling in NDRG1 knockdown cells and increase rate of transferrin recycling in NDRG1 overexpressing cells is consistent with the findings of Taketomi et al., [15], [36].
In earlier studies, Laws et al. (Toxicol. Sci., 58, 366 376, 2000) demonstrated a delay in female rat sexual maturation induced by ATR, effects that could equally have been caused by inhibition of hypothalamic GnRH release.
Comparative pathogenesis studies demonstrated a delay in RB-C22v spread to, and decreased replication in the tonsils, a 102 to 107 log10 reduction in virus titers in lymphoid tissues and blood, and an overall delay in generalization of infection relative to BICv.
Animals receiving vaccines with the PkCSP and or PkSSP2 antigens demonstrated a delay in appearance of parasites in the blood, consistent with killing of sporozoites or infected liver cells and development of fewer liver schizonts [60].
Animals treated with anti-CCL20 antibodies demonstrated a delay in tumor appearance – in the control group on day 28, 100% of animals developed visible tumors, while in the anti-CCL20-treated group, only 60% appeared with tumors on the same day.
